Dr. Reddy's Laboratories' (RDY) Management on Q3 2018 Results - Earnings Call Transcript [Seeking Alpha]
Dr. Reddy's Laboratories Ltd (RDY)
US:NYSE Investor Relations:
drreddys.com/investors
Company Research
Source: Seeking Alpha
Dr. Reddy’s Laboratories Ltd. (NYSE: RDY ) Q3 2018 Earnings Conference Call January 25, 2018 8:00 AM ET Executives Saunak Savla – Head-Investor Relations Saumen Chakraborty – President, Chief Financial Officer and Global Head of IT&BPE Abhijit Mukherjee – Chief Operating Officer Anil Namboodiripad – Senior Vice President, Proprietary Products and Head-Promius Pharma Analysts Manoj Garg – Healthco Prakash Agarwal – Axis Capital Neha Manpuria – JPMorgan Anubhav Agarwal – Credit Suisse Christian Glennie – Stifel Sebastian Sauter – RBC Capital Markets Saion Mukherjee – Nomura Securities Manushi Shah – Research Delta Advisors Sameer Baisiwala – Morgan Stanley Chirag Talati – Kotak Securities Shyam Srinivasan – Goldman Sachs Vishal Manchanda – Nirmal Bang Kartik Mehta – Deutsche Bank Nitin Agarwal – IDFC Securities Operator Ladies and gentlemen, good day, and welcome to Dr. Reddy’s Laboratories Limited Q3 FY2018 Earnings Conference Call.
Show less
Read more
Impact Snapshot
Event Time:
RDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RDY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RDY alerts
High impacting Dr. Reddy's Laboratories Ltd news events
Weekly update
A roundup of the hottest topics
RDY
News
- Super Generics Market Size Will Reach USD 128.62 Billion to 2031 - Revealed InsightAce Latest Study [Yahoo! Finance]Yahoo! Finance
- Indian shares set to open lower on fading US rate cut hopes [Reuters]Reuters
- Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Aurigene Pharmaceutical Services Ltd. introduces Aurigene.AI™, an artificial intelligence (AI) and machine learning (ML) assisted drug discovery platform [Yahoo! Finance]Yahoo! Finance
- Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates [Yahoo! Finance]Yahoo! Finance
RDY
Earnings
- 1/31/24 - Beat
RDY
Sec Filings
- 4/25/24 - Form 6-K
- 4/25/24 - Form 6-K
- 4/23/24 - Form 6-K
- RDY's page on the SEC website